Neuroone Medical Technologies is trading at $1.84, down -9.36%, with no clear company-specific announcement or overnight catalyst identified for August 24, 2026.
- Latest results, released August 13, showed 16% year-over-year revenue growth, a $2.0 million net loss, and a smaller cash balance.
- Broader futures were modestly lower, but the decline appears too large to confidently attribute solely to market weakness.
- The move may warrant rechecking for delayed news.